Stocks News

LAST PRICE
329.4600
TODAY'S CHANGE (%)
Trending Down-1.8600 (-0.5614%)

Bid / Lots
329.0200/ 2
Ask / Lots
329.9300/ 8
Open / Previous Close
331.0000 / 331.3200
Day Range
Low 316.6650
High 334.9299
52 Week Range
Low 133.9850
High 337.4365
Volume
542,002
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: MDGL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:22 ET (16:22 GMT)
- B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $236 From $194, Maintains Neutral Rating, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: MDGL
  09:14 AM EST, 11/05/2024 (MT Newswires) -- Madrigal Pharmaceuticals (MDGL) has an average outperform rating and price target range of $155 to $530, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resea...
Nov 1, 2024
- DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones
  2:37PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MDGL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 14:37 ET (18:37 GMT)
- UBS Adjusts Price Target on Madrigal Pharmaceuticals to $441 From $411, Maintains Buy Rating, from 10:07AM ET on Friday Nov 01, 2024 by MT Newswires
  10:07AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: MDGL
  10:07 AM EDT, 11/01/2024 (MT Newswires) -- Madrigal Pharmaceuticals (MDGL) has an average outperform rating and price target range of $155 to $511, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resea...
Oct 31, 2024
- Sector Update: Health Care Stocks Softer Late Afternoon, from 3:52PM ET on Thursday Oct 31, 2024 by MT Newswires
  3:52PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: MRK, EQ, MDGL, MTNB
  03:52 PM EDT, 10/31/2024 (MT Newswires) -- Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) off 0.3%. The iShares Biotechnology ETF (IBB) fell 1.2%. In c...

Today
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: VKTX
- DJ Viking Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: VKTX
- Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Palantir Technologies, Hims & Hers Health to Open Higher, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: NVDA, TSLA, AMD, HIMS, PLTR, DJT, SMCI, VKTX
Yesterday
- Nuvalent Insider Sold Shares Worth $442,980, According to a Recent SEC Filing, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: NUVL
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 22 hours ago by Dow Jones
  22 hours ago by Dow Jones
  Companies Mentioned: CYTK
- DJ This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo. -- Barrons.com, from 9:59AM ET on Monday Nov 04, 2024 by Dow Jones
  9:59AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, VKTX
- Oppenheimer Adjusts Viking Therapeutics Price Target to $164 From $138, Maintains Outperform Rating, from 8:58AM ET on Monday Nov 04, 2024 by MT Newswires
  8:58AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: VKTX
- Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday as Investors Focus on Election, Fed Policy Meeting, from 8:45AM ET on Monday Nov 04, 2024 by MT Newswires
  8:45AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, INTC, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, RILY, NVDA, QQQ, SPY, LEU, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, YUMC, ATSG, XSD, RTH, USO, SLV, XRT, EXI, BITO, UNG, VKTX, EEM
- DJ S&P 500 Futures Climb In Premarket Trading; Talen Energy, Constellation Energy Lag, from 7:30AM ET on Monday Nov 04, 2024 by Dow Jones
  7:30AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: MOS, YUMC, NTR, NTR, CEG, VKTX, TLN, KVYO
- Stocks Gain Pre-Bell Ahead of Presidential Elections, Fed Policy Decision; Asia, Europe Rise, from 7:22AM ET on Monday Nov 04, 2024 by MT Newswires
  7:22AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: ILMN, L, MAR, NVDA, NYT, RVTY, TSLA, NXPI, VRTX, AIG, FOX, FOXA, ZTS, BNTX, BEN, PLTR, CEG, FIS, VKTX, FRPT

Madrigal Pharmaceuticals Inc
NASDAQ:MDGLUnited States

Search Criteria

Today

DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 3 hours ago by Dow Jones

B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $236 From $194, Maintains Neutral Rating, from 5 hours ago by MT Newswires

Nov 1, 2024

DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones

UBS Adjusts Price Target on Madrigal Pharmaceuticals to $441 From $411, Maintains Buy Rating, from 10:07AM ET on Friday Nov 01, 2024 by MT Newswires

Oct 31, 2024

Sector Update: Health Care Stocks Softer Late Afternoon, from 3:52PM ET on Thursday Oct 31, 2024 by MT Newswires

Peers Headlines

Today

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 2 hours ago by Dow Jones

DJ Viking Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 5 hours ago by Dow Jones

Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Palantir Technologies, Hims & Hers Health to Open Higher, from 7 hours ago by MT Newswires

Yesterday

Nuvalent Insider Sold Shares Worth $442,980, According to a Recent SEC Filing, from 22 hours ago by MT Newswires

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 22 hours ago by Dow Jones

DJ This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo. -- Barrons.com, from 9:59AM ET on Monday Nov 04, 2024 by Dow Jones

Oppenheimer Adjusts Viking Therapeutics Price Target to $164 From $138, Maintains Outperform Rating, from 8:58AM ET on Monday Nov 04, 2024 by MT Newswires

Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday as Investors Focus on Election, Fed Policy Meeting, from 8:45AM ET on Monday Nov 04, 2024 by MT Newswires

DJ S&P 500 Futures Climb In Premarket Trading; Talen Energy, Constellation Energy Lag, from 7:30AM ET on Monday Nov 04, 2024 by Dow Jones

Stocks Gain Pre-Bell Ahead of Presidential Elections, Fed Policy Decision; Asia, Europe Rise, from 7:22AM ET on Monday Nov 04, 2024 by MT Newswires